Psychiatry

Investigators systematically review data to further understand the relationship between sleep and PTSD as it impacts treatment outcomes.

The analysis of 500+ patients with ADHD shows no statistically significant evidence linking stimulant treatment to later substance use, indicating that stimulant medication did not increase or decrease the risk of substance use in adolescence or adulthood.

A systematic review and meta-analysis of 10 studies observed that visual impairment significantly increased the risk of suicidal ideation, suicide attempt, and suicide death.

The prospective cohort study evaluates the role of both subjective and objective experiences.

From a novel acne cream to a breakthrough depression drug, a half-dozen agent decisions are coming through in the coming 6 months.

The data provide promising results, yielding a smoking abstinence rate of 26.4% in the intervention group at 18 months.

Telehealth likely will have a major place in psychiatric care in the future.

For participants reporting past-year suicidal experiences, there was decreased odds of attributing their suicidal experiences to the pandemic for veterans compared to nonveterans.

The investigators found an adjusted odds ratio of 1.74 for hospitalized suicide attempts and 1.45 for those who committed suicide in individuals with recent psychiatric history.

Reports from the intervention group show decreased alcohol-related problems, mediated by the change in insomnia severity following treatment.

The guidelines contain safety warnings because psychedelic drugs could produce psychoactive effects such as mood, cognitive changes, and hallucinations.

The results show 55.4% of patients in the ketamine group had a response, compared to 41.2% of patients in the ECT group.

Patients with high attendance rates within the lifestyle intervention group lost more weight than those with medium and low rates.

Patients with anxiety or depression who engaged in health-related social media usage were significantly more likely to report to report intentions to quit smoking, endorse past 12-month attempts at smoking cessation, and were more likely to meet national recommendation for weekly strength training.

The results show high centrality of anxiety and depression in patients with COVID-19 and anxiety had the highest bridge influence in the network.

After making adjustments, the results show a positive association between alcohol dependence at 18 years and depression at age 24 years. However, there was no association between the rate of change and depression.

The new guidelines call for MDD screening for adults, including pregnant and postpartum individuals and those aged 65 years and older, which would have a moderate net benefit.

New CDC survey data show an estimated 47 million adults in the US have ever been diagnosed with depression, with clear disparities based on demographics and regions.

Young adults with psychiatric and behavioral disorders are more likely to experience a decline in sleep intensity and sleep depth more dramatically after adolescence.

The results of the study presented during SLEEP 2023 show the rate of suicidality was 46% in individuals who reported moderate-to-severe nightmares.

A preference for eveningness was significantly associated with worse overall sleep difficulties, longer sleep latency, reduced sleep satisfaction, more prolonged sleep inertia, more daytime naps, and more severe depressive symptomatology.

The results show engagement in the Telehealth Collaborative Care program visits was greater compared to the Telehealth Enhanced Referral group.

Participants who only initiated non-stimulant therapy for ADHD had significantly greater odds of past-year prescription stimulant misuse than the population controls.

Patients with comorbid major depressive disorder were more likely to have a diagnoses of tobacco, alcohol, opioid, cannabis, stimulants, hallucinogens, sedatives-hypnotics, or anxiolytic use disorders compared to patients with only systemic lupus erythematous.

The rate of sleep apnea is greater in patients with bipolar disorder and depression.